MDRGN are defined as “Enterobacterales with extended spectrum beta-lactamase (ESBL)–phenotype as well as Enterobacterales, and Acinetobacter baumannii resistant against piperacillin, any 3rd/4th generation cephalosporin, and fluoroquinolones ± carbapenems”, as previously described [11], [12]. In case of carbapenem-resistance, the addendum “CR” is given.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.